William Blair & Company
EW icon

William Blair & Company’s Edwards Lifesciences EW Stock Holding History

William Blair & Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,400
Closed -$75K – 1638
2017
Q1 		$75K Hold
2,400
– – ﹤0.01% 1309
2016
Q4 		$75K Buy
+2,400
New +$77.8K ﹤0.01% 1236

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

William Blair & Company's EW Position: Q1 2026 in Review

William Blair & Company reduced its Edwards Lifesciences (EW) stake by 8.4% in Q1 2026, selling an estimated $2.4M and leaving 315,690 shares worth $25.3M. The position accounts for 0.07% of the portfolio, ranked #219.

William Blair & Company first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $122M in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • William Blair & Company held 315,690 shares of Edwards Lifesciences worth $25.3M as of Q1 2026.
  • William Blair & Company sold 29,110 Edwards Lifesciences shares in Q1 2026, an estimated $2.4M.
  • Edwards Lifesciences made up 0.07% of William Blair & Company's portfolio in Q1 2026, its #219 holding.
  • William Blair & Company first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Edwards Lifesciences position peaked at $122M in Q4 2021.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.